Kyrgyzstan

Reimbursed Care Access

Kyrgyzstan maintains broad criminal prohibitions on the possession, production and trafficking of narcotic and psychotropic substances under its Criminal Code, while certain controlled substances used as medicines (most notably ketamine as an anaesthetic) are procured and used in health-care settings under prescription rules. There is no public evidence of national regulatory approval or public reimbursement frameworks for psychedelic compounds such as psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca, mescaline or 2C‑X; those compounds remain treated as controlled/illicit outside of tightly controlled research or criminal-law exceptions. Where a compound is used medically (ketamine), procurement and prescribing are regulated by the Ministry of Health and institutional procurement (tenders) rather than by a reimbursed, routine psychedelic‑therapy programme. [https://cdn.nestjs.wipolex.wji.prd.web1.wipo.int/wipolex/en/legislation/details/17494|Criminal Code of the Kyrgyz Republic], [https://tenderimpulse.com/all-tender-list-from-country/get-krygyzstan-tenders/2023-10-16/1|Kyrgyzstan procurement listing: Ketamine].